Annual Working Capital
$253.39 M
-$39.06 M-13.36%
December 31, 2024
Summary
- As of March 10, 2025, FATE annual working capital is $253.39 million, with the most recent change of -$39.06 million (-13.36%) on December 31, 2024.
- During the last 3 years, FATE annual working capital has fallen by -$298.74 million (-54.11%).
- FATE annual working capital is now -54.11% below its all-time high of $552.13 million, reached on December 31, 2021.
Performance
FATE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$253.39 M
-$19.48 M-7.14%
December 31, 2024
Summary
- As of March 10, 2025, FATE quarterly working capital is $253.39 million, with the most recent change of -$19.48 million (-7.14%) on December 31, 2024.
- Over the past year, FATE quarterly working capital has dropped by -$19.48 million (-7.14%).
- FATE quarterly working capital is now -64.30% below its all-time high of $709.74 million, reached on March 31, 2021.
Performance
FATE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
FATE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.4% | -7.1% |
| 3 y3 years | -54.1% | -7.1% |
| 5 y5 years | +27.1% | -7.1% |
FATE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.1% | at low | -54.1% | at low |
| 5 y | 5-year | -54.1% | +27.1% | -64.3% | +38.2% |
| alltime | all time | -54.1% | +8309.8% | -64.3% | >+9999.0% |
Fate Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $253.39 M(-13.4%) | $253.39 M(-7.1%) |
| Sep 2024 | - | $272.87 M(-4.1%) |
| Jun 2024 | - | $284.60 M(-18.5%) |
| Mar 2024 | - | $349.01 M(+19.3%) |
| Dec 2023 | $292.45 M(-24.6%) | $292.45 M(-9.4%) |
| Sep 2023 | - | $322.84 M(-7.1%) |
| Jun 2023 | - | $347.49 M(-10.7%) |
| Mar 2023 | - | $389.24 M(+0.3%) |
| Dec 2022 | $388.02 M(-29.7%) | $388.02 M(-10.1%) |
| Sep 2022 | - | $431.39 M(-15.0%) |
| Jun 2022 | - | $507.64 M(-2.6%) |
| Mar 2022 | - | $521.16 M(-5.6%) |
| Dec 2021 | $552.13 M(+35.1%) | $552.13 M(-8.3%) |
| Sep 2021 | - | $601.83 M(-1.0%) |
| Jun 2021 | - | $607.67 M(-14.4%) |
| Mar 2021 | - | $709.74 M(+73.6%) |
| Dec 2020 | $408.76 M(+105.1%) | $408.76 M(-7.6%) |
| Sep 2020 | - | $442.58 M(-10.6%) |
| Jun 2020 | - | $494.90 M(+170.0%) |
| Mar 2020 | - | $183.32 M(-8.0%) |
| Dec 2019 | $199.28 M(+12.0%) | $199.28 M(-24.8%) |
| Sep 2019 | - | $265.04 M(+95.2%) |
| Jun 2019 | - | $135.76 M(-13.7%) |
| Mar 2019 | - | $157.29 M(-11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $177.93 M(+94.4%) | $177.93 M(-7.0%) |
| Sep 2018 | - | $191.26 M(+200.0%) |
| Jun 2018 | - | $63.76 M(-18.3%) |
| Mar 2018 | - | $78.04 M(-14.8%) |
| Dec 2017 | $91.55 M(+17.2%) | $91.55 M(+51.8%) |
| Sep 2017 | - | $60.32 M(-5.5%) |
| Jun 2017 | - | $63.81 M(-4.1%) |
| Mar 2017 | - | $66.54 M(-14.8%) |
| Dec 2016 | $78.14 M(+49.7%) | $78.14 M(+138.8%) |
| Sep 2016 | - | $32.72 M(-0.1%) |
| Jun 2016 | - | $32.77 M(-23.2%) |
| Mar 2016 | - | $42.68 M(-18.3%) |
| Dec 2015 | $52.21 M(+15.3%) | $52.21 M(-15.2%) |
| Sep 2015 | - | $61.59 M(-12.3%) |
| Jun 2015 | - | $70.26 M(+93.1%) |
| Mar 2015 | - | $36.38 M(-19.7%) |
| Dec 2014 | $45.29 M(-9.5%) | $45.29 M(+8.6%) |
| Sep 2014 | - | $41.71 M(+8.5%) |
| Jun 2014 | - | $38.43 M(-12.5%) |
| Mar 2014 | - | $43.91 M(-12.3%) |
| Dec 2013 | $50.05 M(+912.6%) | $50.05 M(+405.8%) |
| Sep 2013 | - | $9.89 M(-836.8%) |
| Jun 2013 | - | -$1.34 M(-127.2%) |
| Dec 2012 | $4.94 M(+64.1%) | $4.94 M |
| Dec 2011 | $3.01 M | - |
FAQ
- What is Fate Therapeutics annual working capital?
- What is the all time high annual working capital for Fate Therapeutics?
- What is Fate Therapeutics annual working capital year-on-year change?
- What is Fate Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Fate Therapeutics?
- What is Fate Therapeutics quarterly working capital year-on-year change?
What is Fate Therapeutics annual working capital?
The current annual working capital of FATE is $253.39 M
What is the all time high annual working capital for Fate Therapeutics?
Fate Therapeutics all-time high annual working capital is $552.13 M
What is Fate Therapeutics annual working capital year-on-year change?
Over the past year, FATE annual working capital has changed by -$39.06 M (-13.36%)
What is Fate Therapeutics quarterly working capital?
The current quarterly working capital of FATE is $253.39 M
What is the all time high quarterly working capital for Fate Therapeutics?
Fate Therapeutics all-time high quarterly working capital is $709.74 M
What is Fate Therapeutics quarterly working capital year-on-year change?
Over the past year, FATE quarterly working capital has changed by -$19.48 M (-7.14%)